Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CLIN.L Share News (CLIN)
CLIN Share
Price
CLIN Share
News
CLIN Share
Chat
CLIN Share
Trades
CLIN
Live RNS
CLIN Share
Charts
CLIN Broker
Ratings
CLIN Directors
Deals
CLIN Financial
Diary
CLIN
Fundamentals
CLIN Short
Positions
CLIN
Media
CLIN Company
Research
CLIN Company
Timeline
- There is currently no data for CLIN
Clinigen reiterates guidance after 'solid' first half
The AIM-traded firm said that as usual, it expected to see a second-half weighting to the full-year numbers.
It said its leverage on 31 December was expected to be 2.5x, "meaningfully below" the group's temporary banking covenant of 3.5x.
"During the first half of the year we have seen a solid performance across both the services and products divisions," said group chief executive officer Shaun Chilton.
"We remain mindful of the continued prevalence of the Covid-19 Omicron variant, which has the potential to impact our principal markets.
"However, we continue to perform well on those elements within our control and remain focussed on building the lifecycle platform to service the needs of pharma companies and healthcare professionals around the globe."
At 1115 GMT, shares in Clinigen Group were down 0.54% at 917p.
Latest CLIN News
- EXECUTIVE CHANGES: Clinigen taps new chair; essensys hires from WeWork
3 Aug 2021 - IN BRIEF: Clinigen to manage distribution of epilepsy drug Kigabeq
21 Jul 2021 - Wednesday broker round-up
14 Jul 2021 - Clinigen expects annual revenue rise in transitional year
13 Jul 2021 - Clinigen ends year in line with expectations
13 Jul 2021 - Sunday share tips: Clinigen, UK companies
11 Jul 2021 - BROKER RATINGS: Berenberg says buy Shaftesbury, Capital & Counties
7 Jul 2021 - Clinigen to sell UK specials business for up to £7.8m
30 Jun 2021
Related News
IN BRIEF: UK court sanctions Titon takeover of Clinigen
Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceutical services - Says Thursday that its takeover by Triton Investment Management Lt...
AIM faces trading volume cliff as three most active stocks exit
(Alliance News) - The three most active stocks on the AIM market in London are set to depart all at once, potentially leaving a gap in trading volume ...
TRADING UPDATES: IPF swings to profit; Seraphine lowers outlook
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
CLIN.L News
EXECUTIVE CHANGES: Clinigen taps new chair; essensys hires from WeWork
EXECUTIVE CHANGES: Clinigen taps new chair; essensys hires from WeWork
IN BRIEF: Clinigen to manage distribution of epilepsy drug Kigabeq
IN BRIEF: Clinigen to manage distribution of epilepsy drug Kigabeq
Wednesday broker round-up
(Sharecast News) - Carnival: Berenberg upgrades to hold with a target price of 1,400p.
Clinigen expects annual revenue rise in transitional year
Clinigen expects annual revenue rise in transitional year
Clinigen ends year in line with expectations
(Sharecast News) - Pharmaceutical products and services company Clinigen updated the market on its just-ended financial year on Tuesday, saying net re...
Sunday share tips: Clinigen, UK companies
(Sharecast News) - The Sunday Times's Sabah Meddings told readers to 'hold' shares of Clinigen amid some resurgent 'market chatter' regarding a possib...
BROKER RATINGS: Berenberg says buy Shaftesbury, Capital & Counties
BROKER RATINGS: Berenberg says buy Shaftesbury, Capital & Counties
Clinigen to sell UK specials business for up to £7.8m
(Sharecast News) - Pharmaceutical company Clinigen has agreed the disposal of its non-core UK specials manufacturing and aseptic compounding business ...
Follow the stocks
